1 Min Read
Nov 7 (Reuters) - Neovacs SA :
* Neovacs enrolls the first US patient in phase IIb study of IFNa Kinoid for treatment of Systemic Lupus Erythematosus (SLE) Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.